ERJ: pick of the week

Lung cancer screening with low-dose computed tomography has been recommended for stepwise implementation in Europe. A high-quality programme is essential for clinical and cost-effectiveness. This ERS technical standard defines the standards needed to achieve this. Read the article in full at erj.ersjournals.com 

Breathe: climate change, the environment and respiratory disease

The latest issue of Breathe focuses on respiratory disease and the environment, with articles looking at occupational lung disease, and air quality and respiratory health in children. The journal club looks at three recent publications investigating the effects of environmental exposures on respiratory health outcomes. Read the introduction editorial from the Breathe Chief Editor, Brian D. Kent. Browse the full table of contents. 

Current situation and therapeutic perspectives in cystic fibrosis

A recent ERS Vision Live panel discussion focused on the current situation and therapeutic perspectives in cystic fibrosis. In a discussion chaired by Dr Eva Polverino and Mr Dimitris Kontopidis, expert panellists considered new therapies, strategies for infection management and new approaches to the management of adult cystic fibrosis patients.

Watch the recording | Access the ERS Monograph on Cystic Fibrosis

ERJ: pick of the week

In patients with interstitial lung disease, rituximab plus mycophenolate mofetil (MMF) is associated with benefits in lung function and progression-free survival compared with MMF plus placebo after 24 weeks of treatment. The safety profile of rituximab plus MMF was similar to that of MMF plus placebo. Read the article in full at erj.ersjournals.com 

New ERS Monograph: Rare Diseases of the Respiratory System – online now!

The latest ERS Monograph on Rare Diseases of the Respiratory System has now been published. Written and edited by authors who support the vision and mission of ERN-LUNG, the book covers: identification of rare diseases of the respiratory system and their differential diagnosis; rare diseases of the lung interstitium; rare diseases of the airways or alveoli; and rare pulmonary vascular diseases. Access the Monograph online

Clean Air in Europe for All

The European Respiratory Society (ERS), the International Society for Environmental Epidemiology (ISEE) and the Health Effects Institute (HEI) recently held Clear Air in Europe for All – a one-day conference focused on air pollution. International experts, policy makers, scientists and other key stakeholders gathered together to call for immediate and decisive action to tackle air quality in Europe. Topics discussed included: the recently proposed revision to the EU Ambient Air Quality Directive (AAQD); the remaining challenges; and additional policy options.

View the presentations | Access the ERS Monograph on Occupational and Environmental Lung Disease

Time to Breathe

In the latest instalment of the Time to Breathe video series, co-authors Adel Mansur and Nagakumar Prasad talk to Emer Kelly about their Breathe article, "Management of difficult-to-treat asthma in adolescence and young adults". Watch the video and visit breathe.ersjournals.com to browse the ERS's free-to-access educational publication.

The ERS Monograph podcast: listen to the newest episodes

The ERS Monograph podcast provides a fascinating overview of the latest instalments in our book series. Each episode looks at a different Monograph, with interviews featuring Guest Editors and leaders in the field. On the ERS Respiratory Channel, you'll find podcast episodes on inequalities in respiratory health, lung diseases and cancer, complex breathlessness, and much more.

Visit the ERS Respiratory Channel

Biologics as disease-modifying agents in severe asthma

The latest episode of Coffee Talk on the ERS Respiratory Channel focuses on biologics as disease-modifying agents in severe asthma, as Rekha Chaudhuri, Honourary Professor in the School of Infection and Immunity at the University of Glasgow, speaks to Professor Peter Howarth, Emeritus Professor of Allergy and Respiratory Medicine at the University of Southampton.

Watch Coffee Talk | Access the ERS Monograph on Severe Asthma

Access the latest ERJ Open Research articles

The most recent papers published in ERJ Open Research – ERS's fully open access research journal – include: a Review on chronic cough; the RISE study protocol; and original articles that ask "What bothers severe asthma patients most?", that consider the effects of dual IQOS and cigarette smoke exposure on airway epithelial cells, and that examine patient attitudes to nebulised antibiotics in the treatment of bronchiectasis. Visit openres.ersjournals.com to browse all of the latest articles in full.

ERJ Open Research: pick of the week

The use of multiple electronic nicotine delivery products is on the rise. While the potential harm associated with dual- or poly-product usage is not yet clear, this study suggests that dual cigarette smoking and heated tobacco product use may be detrimental to lung health. Read the full article at openres.ersjournals.com

Guidelines in Focus: palliative care for COPD or ILD

In the latest instalment in the Guidelines in Focus series on the ERS Respiratory Channel, Professor Ioannis Vogiatzis speaks to Professor Daisy Janssen, Co-Chair of the European Respiratory Society Clinical Practice Guideline: Palliative care for people with chronic obstructive pulmonary disease or interstitial lung disease. Two patient representatives, Albert Devilliers and Chantal Vandendungen, then share their experiences of living with interstitial lung disease and their preferences around palliative care.

Watch the interview | Access the guidelines in full

Celebrating 100 issues of the ERS Monograph!

We are celebrating 100 issues of the ERS Monograph with a very special offer – buy four or more Monograph titles in print and receive a 20% discount. Visit ersbookshop.com to browse the Monographs and help us celebrate the ongoing success of the European Respiratory Society's long-running, authoritative book series.

Neonatal interstitial lung disease

Childhood interstitial lung disease (chILD) is a heterogeneous group of rare respiratory disorders with high morbidity and mortality. As ILD before 2 years of age is very rare, centres encounter a limited number of patients per year. On 20 June, a joint European Respiratory Society (ERS)/European Society for Paediatric Research (ESPR) webinar will discuss the optimal management of this condition.

Register for the webinar | Order a print copy of Rare Diseases of the Respiratory System | Order a print copy of Respiratory Diseases of the Newborn Infant

Exacerbations in COPD

On 19 June, the European Respiratory Society (ERS) will hold a panel discussion on exacerbations in COPD. Chaired by Dr Emer Kelly, this webinar will cover: definitions of COPD exacerbations; exacerbation severity assessment and the risk of further exacerbations; the suggested duration of antibiotic and steroid use for exacerbations; post-COVID-era use of tele-monitoring in COPD follow-up; and the role of "shielding" in the future. 

Register for the webinar | Order a print copy of Controversies in COPD

ERJ: pick of the week

MUC-031 is a novel thiol-saccharide mucolytic drug. It is potent and fast-acting in rheology-based sputum assays, and improves mucus obstruction, airway inflammation and survival in a mouse model of muco-obstructive lung disease. Read the article in full at erj.ersjournals.com 

New podcast: Inequalities in Respiratory Health

"We need to be better at linking environmental health with human health" 

Ian Sinha and Jennifer Quint talk to ERS Monograph Editorial Board member Holly Keir about how the latest issue of the Monograph – Inequalities in Respiratory Health – can be used as a force for positive change. Their topical and thought-provoking discussion covers: ways in which clinicians can address inequality in their day-to-day practice; the current and future impact of air quality; and the key challenges we face in health inequality and how to address them. As Ian says, "this Monograph gives people a resource that can help them make the changes they feel should happen."

Listen to the podcast | Order your print copy of the Monograph

Celebrating 100 issues of the ERS Monograph!

We are celebrating 100 issues of the ERS Monograph with a very special offer – buy four or more Monograph titles in print and receive a 20% discount. Visit ersbookshop.com to browse the Monographs and help us celebrate the ongoing success of the European Respiratory Society's long-running, authoritative book series.

ERJ Editors' Choice

The Chief Editors of the European Respiratory Journal (ERJ) have selected their article highlights from the May issue. Topics covered include: the association of autoantibodies with disease progression in IPF, long COVID, and minimal clinically important difference for impulse oscillometry in adults with asthma. The issue also includes Air Pollution and COPD: GOLD 2023 Committee Report. Access the Chief Editors' full list or visit erj.ersjournals.com to browse the ERJ, the most highly regarded peer-reviewed respiratory journal in Europe.

Coming soon from the ERS Monograph

Look out for the following titles, coming soon in the ERS Monograph book series: Rare Diseases of the Respiratory System, The Challenge of Tuberculosis in the 21st Century, Digital Respiratory Healthcare and COPD in the 21st Century. Visit ersbookshop.com to browse all the titles in the ERS Monograph collection.

ERJ: pick of the week

This study, published in the European Respiratory Journal, demonstrates that pulmonologists improve their individual diagnostic interpretation of pulmonary function tests when supported by artificial intelligence-based computer protocols with automated explanations. Read the article in full at erj.ersjournals.com